MedPath

The Change of NK Cell Activity After Head and Neck Cancer Surgery

Completed
Conditions
The Patients Undergoing Head and Neck Surgery Including Tumor Removal and Reconstruction With Flap
Registration Number
NCT02661776
Lead Sponsor
Yonsei University
Brief Summary

Cellular immunity can be changed after surgery and anesthesia. Tissue injury by surgical procedures significantly reduces the immune function in proportion to the degree of tissue injury. In addition, the use of opioids as analgesics during the perioperative period depress cellular immunity, in particular the activity of the natural killer (NK) cells. This perioperative immunosuppression may cause deleterious consequences on postoperative outcome in cancer patients. The aim of this study is to confirm the presence or extent of the change of NK cell activity between before and after head and neck surgery. Additionally, investigators will identify the clinical or genetic factors related to the change of NK cell activity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  1. The patients undergoing head and neck surgery including tumor removal and reconstruction with flap
Exclusion Criteria
  1. patients refusal
  2. patients not able to read, or understand the consent form
  3. History of Active viral or bacterial infection
  4. History of use of immunosuppressive drugs within the last six months
  5. History of chemotherapy
  6. History of autoimmune disorders
  7. Known HIV, Hepatitis B, or Hepatitis C infection
  8. Female who is pregnant, nursing
  9. ethnicity, other than asian

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change of NK cell activity24 hours

Preoperative NK cell activity will be measured using the NK vue diagnostic test before surgery and anesthesia. Postoperative NK cell activity will be measured using the NK vue diagnostic test after 24 hours since stopping the use of intravenous remifentanil as analgesics during anesthesia in the operating room or sedation in the intensive care unit.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath